Latest Articles and Analysis

A new Senate bill would require 340B hospitals to document where their savings go and, for the first time, mandate direct discounts for low-income patients at the pharmacy counter. Here's what the proposal contains and why the stakes are high for the communities 340B was built to serve.

New Phase 3 data show a single-tablet regimen of bictegravir/lenacapavir could finally bring one-pill simplicity to long-term HIV survivors locked into complex regimens by decades of drug resistance. The science is closing the treatment gap. Will our policy systems do the same?

HRSA's 340B pilot program replicates existing successful models rather than addressing structural program exploitation.